Sertaconazole vs. Clotrimazole Vaginal Suppositories for Treating Vaginal Candidiasis in Pregnant Women: A Randomized Trial

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
pregnant_thmbnl
Detail Image
pregnant_mbl
Book Detail
Upload PDF
SERTAC_1.PDF (1.14 MB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

A double-blinded, randomized trial found that a single dose of sertaconazole (300 mg) was as effective as clotrimazole (500 mg) in treating acute vaginal candidiasis during pregnancy. Both treatments showed comparable clinical and microscopic cure rates, patient satisfaction, side effects, time to recovery, recurrence rates, and pregnancy outcomes. The study highlights sertaconazole ovules as a viable alternative to the traditionally used clotrimazole vaginal tablets for managing vaginal candidiasis in pregnant women.

Published Date